Literature DB >> 11729418

Medication noncompliance: what is the problem?

C M Dezii.   

Abstract

Mesh：

Year:  2000        PMID： 11729418

Source DB:  PubMed          Journal:  Manag Care        ISSN： 1062-3388


× No keyword cloud information.
  13 in total

1.  Obesity Modifies the Association of Race/Ethnicity with Medication Adherence in the CARDIA Study.

Authors:  Maribel Salas; Catarina I Kiefe; Pamela J Schreiner; Yongin Kim; Lucia Juarez; Sharina D Person; O Dale Williams
Journal:  Patient       Date:  2008-01-01       Impact factor: 3.883

2.  [Treatment adherence and persistence: causes, consequences and improvement strategies].

Authors:  Tatiana Dilla; Amparo Valladares; Luis Lizán; José Antonio Sacristán
Journal:  Aten Primaria       Date:  2009-05-07       Impact factor: 1.137

3.  Physician remuneration methods for family physicians in Canada: expected outcomes and lessons learned.

Authors:  Dominika W Wranik; Martine Durier-Copp
Journal:  Health Care Anal       Date:  2009-01-27

4.  Beliefs and practices of Greek doctors in relation to patients' adherence to antihypertensive medication.

Authors:  A Barbouni; M Nalmpanti; D Gennimata; D Theodoridis; K Merakou
Journal:  J Hum Hypertens       Date:  2016-12-29       Impact factor: 3.012

5.  Clinical utility of fixed-combination telmisartan-amlodipine in the treatment of hypertension.

Authors:  Julian Segura; Luis M Ruilope
Journal:  Integr Blood Press Control       Date:  2011-05-19

6.  Cost-effectiveness analysis of low density lipoprotein cholesterol-lowering therapy in hypertensive patients with type 2 diabetes in Korea: single-pill regimen (amlodipine/atorvastatin) versus double-pill regimen (amlodipine+atorvastatin).

Authors:  Ji-Hyun Park; Yong-Ho Lee; Su-Kyoung Ko; Bong-Soo Cha
Journal:  Epidemiol Health       Date:  2015-02-22

7.  Real-world impact of reminder packaging on antihypertensive treatment adherence and persistence.

Authors:  Leon Dupclay; Michael Eaddy; James Jackson; Aditya Raju; Andrew Shim
Journal:  Patient Prefer Adherence       Date:  2012-07-18       Impact factor: 2.711

Review 8.  Compliance and fixed-dose combination therapy.

Authors:  Sripal Bangalore; Anupama Shahane; Sanobar Parkar; Franz H Messerli
Journal:  Curr Hypertens Rep       Date:  2007-06       Impact factor: 4.592

Review 9.  Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Vasc Health Risk Manag       Date:  2008

10.  Reversion of AHRR Demethylation Is a Quantitative Biomarker of Smoking Cessation.

Authors:  Robert Philibert; Nancy Hollenbeck; Eleanor Andersen; Shyheme McElroy; Scott Wilson; Kyra Vercande; Steven R H Beach; Terry Osborn; Meg Gerrard; Frederick X Gibbons; Kai Wang
Journal:  Front Psychiatry       Date:  2016-04-06       Impact factor: 4.157
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.